R1 RCM Inc
NASDAQ:RCM
R1 RCM Inc
NASDAQ:RCM
Price:
12.31 USD
-1.52%
Market Closed
Updated:
May 17, 2024
R1 RCM Inc
Interest Income Expense
|
R1 RCM Inc
Interest Income Expense Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
R1 RCM Inc
NASDAQ:RCM
|
Interest Income Expense
-$126.9m
|
CAGR 3-Years
-94%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Interest Income Expense
-$369.4m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
1%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Interest Income Expense
-$151m
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-1%
|
|
|
CVS Health Corp
NYSE:CVS
|
Interest Income Expense
-$2.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-18%
|
|
|
Cigna Corp
NYSE:CI
|
Interest Income Expense
-$3.3B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Interest Income Expense
-$187.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-9%
|
See Also
What is R1 RCM Inc's Interest Income Expense?
Interest Income Expense
-126.9m
USD
-126.9m
USD
Based on the financial report for Dec 31, 2023, R1 RCM Inc's Interest Income Expense amounts to -126.9m USD.
What is R1 RCM Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-37%
-37%
Over the last year, the Interest Income Expense growth was -98%. The average annual Interest Income Expense growth rates for R1 RCM Inc have been -94% over the past three years , -37% over the past five years .
You don't have any saved screeners yet
